Non-aggregated protamine-coated poly(lactide-co-glycolide) nanoparticles of cisplatin crossed blood–brain barrier, enhanced drug delivery and improved therapeutic index in glioblastoma cells:in vitrostudies
Authors:
- Ravi Shankar PandeyRPRavi Shankar Pandey
- Upendra Kumar JainUJUpendra Kumar Jain
- Ramesh ChandraRCRamesh Chandra
- Jitender MadanJMJitender Madan
- 25 April 2014
- journal article
- Published by Taylor & Francis in Journal of Microencapsulation
- Vol. 31 (7) , 685-693
Abstract
Non-aggregated protamine impregnated poly(lactide-co-glycolide) nanoparticles of cisplatin (Pt-PLGA NPs) were synthesized to augment brain delivery. The mean particle size of Pt-PLGA NPs and PLGA NPs were observed to be 173.2 ± 7.9 nm and 140 ± 10.2 nm, respectively. The Pt-PLGA NPs significantly (p < 0.05, one-way analysis of variance; ANOVA) delivered higher amount (172.41 ± 15.04 μg) of cisplatin in comparison to 110.48 ± 4.71 μg by PLGA NPs and 20.83 ± 1.65 μg by cisplatin solution across in vitro bovine brain microvessel endothelial cells. Cisplatin bearing Pt-PLGA NPs was found to be highly cytotoxic to U87 glioblastoma cells with an IC50 of 2.1 μM as compared (one-way ANOVA, p < 0.05) to PLGA NPs (3.9 μM) and cisplatin alone (13.33 μM). Impregnation with Pt enhanced the uptake of PLGA NPs in U87 glioblastoma cells as compared to PLGA NPs by following endocytosis mechanism. Cisplatin-loaded Pt-PLGA NPs compel preclinical tumour regression study to further improve its utility against glioblastoma.Keywords
This publication has 38 references indexed in Scilit:
- Applications of Cell-Penetrating Peptides for Tumor Targeting and Future Cancer TherapiesPharmaceuticals, 2012
- Physicochemical Characterization of Complex Drug Substances: Evaluation of Structural Similarities and Differences of Protamine Sulfate from Various SourcesThe AAPS Journal, 2012
- Encapsulation of Alpha-1 antitrypsin in PLGA nanoparticles: In Vitro characterization as an effective aerosol formulation in pulmonary diseasesJournal of Nanobiotechnology, 2012
- Brain tumor targeting of magnetic nanoparticles for potential drug delivery: Effect of administration route and magnetic field topographyJournal of Controlled Release, 2011
- Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery CarrierPolymers, 2011
- Dissolution Testing for Generic Drugs: An FDA PerspectiveThe AAPS Journal, 2011
- Surface Characteristics of Nanoparticles Determine Their Intracellular Fate in and Processing by Human Blood–Brain Barrier Endothelial Cells In VitroMolecular Therapy, 2011
- Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacyProceedings of the National Academy of Sciences, 2010
- CNS Delivery Via Adsorptive TranscytosisThe AAPS Journal, 2008
- Cationic Albumin–Conjugated Pegylated Nanoparticles Allow Gene Delivery into Brain Tumors via Intravenous AdministrationCancer Research, 2006